Does C-reactive protein to serum Albumin Ratio correlate with diabEtic nephropathy in patients with Type 2 dIabetes MEllitus? The CARE TIME study

Published:September 06, 2021DOI:


      • CAR is elevated in diabetic nephropathy compared to those of without nephropathy.
      • CAR levels were positively and strongly correlated with the presence of DN.
      • CAR have 79% sensitivity and 78% specificity in detecting DN when it is above 0.82%.
      • A unit increase in CAR increased the risk of DN by 3.5 folds.



      Diabetic Nephropathy (DN) is a complication of Diabetes Mellitus and is associated with chronic and low-grade inflammatory burden. Novel inflammatory predictors, such as, C-reactive protein to serum albumin ratio (CAR) has been studied various inflammatory conditions, recently. Increased inflammatory burden accompany to both type 2 Diabetes Mellitus (T2DM) and DN, hence we aimed to compare CAR levels of the T2DM subjects with DN to those of without DN.


      Patients with T2DM were enrolled to the study. Study population grouped into two according to the presence (group A) or absence (group B) of DN. Characteristics and laboratory data, as well as CAR levels; of the study groups were compared.


      Median CAR levels of the groups A and B were 2.17% (0.02−13.2) and 0.39% (0.02−4.39), respectively (p < 0.001). CAR was found to be an independent risk factor for diabetic nephropathy (adjusted to age, BMI, fasting glucose, HbA1c, and body weight). One unit (0.1%) elevation in CAR increased the risk of nephropathy by 3.5 folds (p < 0.001, 95%CI: 2.24–5.45). CAR levels greater than 0.82% have 79% sensitivity and 78% specificity in predicting DN (AUC: 0.86 [95% CI: 0.80−0.92]; p < 0.001).


      In conclusion, elevated CAR levels are higher in type 2 diabetic patients with diabetic nephropathy. According to the ROC curve, a level higher than 0.82% presents the best sensitivity and specificity in the association with the presence of DN.


      To read this article in full you will need to make a payment
      Subscribe to Primary Care Diabetes
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Feng X.
        • Zhao J.
        • Ding J.
        • Shen X.
        • Zhou J.
        • Xu Z.
        LncRNA Blnc1 expression and its effect on renal fibrosis in diabetic nephropathy.
        Am. J. Transl. Res. 2019; 11: 5664
        • Liu B.
        • Qiang L.
        • Wang G.
        • Duan Q.
        • Liu J.
        LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
        Eur. Rev. Med. Pharmacol. Sci. 2019; 23: 3478-3486
        • Zhang L.
        • Jing M.
        • Liu Q.
        Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats via NLRP3 inflammasomes.
        Life Sci. 2021; 119542
        • Kim M.
        • Park Y.-G.
        • Park Y.-H.
        C-reactive protein/albumin ratio as an indicator of disease activity in Behçet’s disease and human leukocyte antigen-B27-associated uveitis.
        Graefes Arch. Clin. Exp. Ophthalmol. 2021; : 1-8
        • Con D.
        • Andrew B.
        • Nicolaides S.
        • van Langenberg D.R.
        • Vasudevan A.
        Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy.
        Intest. Res. 2021; (Online ahead of print)
        • Amin A.T.M.
        • Zaki R.A.
        • Friedmacher F.
        • Sharif S.P.
        C-reactive protein/albumin ratio is a prognostic indicator for predicting surgical intervention and mortality in neonates with necrotizing enterocolitis.
        Pediatr. Surg. Int. 2021; : 1-6
        • Wu M.
        • Guo J.
        • Guo L.
        • Zuo Q.
        The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer.
        Tumor Biol. 2016; 37: 12525-12533
        • Hwang J.-C.
        • Jiang M.-Y.
        • Lu Y.-H.
        • Wang C.-T.
        Precedent fluctuation of serum hs-CRP to albumin ratios and mortality risk of clinically stable hemodialysis patients.
        PLoS One. 2015; 10e0120266
        • Navarro-Gonzalez J.F.
        • Mora-Fernandez C.
        The role of inflammatory cytokines in diabetic nephropathy.
        J. Am. Soc. Nephrol. 2008; 19: 433-442
        • Kocak M.Z.
        • Aktas G.
        • Duman T.T.
        • Atak B.M.
        • Savli H.
        Is uric acid elevation a random finding or a causative agent of diabetic nephropathy?.
        Rev. Assoc. Med. Bras. 2019; 65: 1155-1160
        • Tekce B.K.
        • Tekce H.
        • Aktas G.
        • Sit M.
        Evaluation of the urinary kidney injury molecule-1 levels in patients with diabetic nephropathy.
        Clin. Investig. Med. 2014; : E377-E383
        • Kocak M.Z.
        • Aktas G.
        • Atak B.M.
        • et al.
        Is Neuregulin‐4 a predictive marker of microvascular complications in type 2 diabetes mellitus?.
        Eur. J. Clin. Invest. 2020; 50e13206
        • Atak B.M.
        • Duman T.T.
        • Aktas G.
        • Kocak M.Z.
        • Savli H.
        Platelet distribution width is associated with type 2 diabetes mellitus and diabetic nephropathy and neuropathy.
        Natl. J. Health Sci. 2018; 3: 95-98
        • Kocak M.Z.
        • Aktas G.
        • Duman T.T.
        • et al.
        Monocyte lymphocyte ratio as a predictor of diabetic kidney injury in type 2 diabetes mellitus; the MADKID study.
        J. Diabetes Metab. Disord. 2020; : 1-6
        • Zhao H.
        • Liu H.
        • Qi W.
        • et al.
        Postoperative ratio of C-reactive protein to albumin as a predictive marker in patients with Crohn’s disease undergoing bowel resection.
        Gastroenterol. Res. Pract. 2021; 2021
        • Saylik F.
        • Akbulut T.
        • Kaya S.
        Can C-reactive protein to albumin ratio predict in-hospital death rate due to COVID-19 in patients with hypertension?.
        Angiology. 2021; (00033197211012145, Online ahead of print)
        • Kaplan M.
        • Ates I.
        • Akpinar M.Y.
        • et al.
        Predictive value of C-reactive protein/albumin ratio in acute pancreatitis.
        Hepatobiliary Pancreat. Dis. Int. 2017; 16: 424-430
        • Fang K.-H.
        • Lai C.-H.
        • Hsu C.-M.
        • et al.
        A retrospective study on the prognostic value of preoperative C-reactive protein to albumin ratio in patients with oral cavity squamous cell carcinoma.
        PeerJ. 2020; 8: e9361
        • Chen Y.-Y.
        • Zhang J.-H.
        • Zhang W.
        • Yang Z.-K.
        • Luo R.-C.
        • Kang S.-J.
        C-reactive protein/albumin ratio as a novel inflammation-based prognostic index for predicting outcomes of patients with colorectal cancer.
        J. South. Med. Univ. 2017; 37: 622-627
        • Liao C.-K.
        • Yu Y.-L.
        • Lin Y.-C.
        • et al.
        Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis.
        World J. Surg. Oncol. 2021; 19: 1-10
        • Yu J.
        • Liu H.
        • Zeng X.
        • et al.
        Prognostic and clinicopathological significance of C-reactive protein/albumin ratio (CAR) in patients with gastric cancer: a meta-analysis.
        PLos One. 2021; 16e0250295
        • Xie Q.
        • Wang L.
        • Zheng S.
        Prognostic and clinicopathological significance of C-Reactive protein to albumin ratio in patients with pancreatic cancer: a meta-analysis.
        Dose-Response. 2020; 18 (1559325820931290)
        • Liu Y.
        • Chen S.
        • Zheng C.
        • et al.
        The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
        BMC Cancer. 2017; 17: 1-8
        • Ni X.F.
        • Wu J.
        • Ji M.
        • et al.
        Effect of C‐reactive protein/albumin ratio on prognosis in advanced non–small‐cell lung cancer.
        Asia Pac. J. Clin. Oncol. 2018; 14: 402-409
        • Zhang Y.
        • Zhou G.-Q.
        • Liu X.
        • et al.
        Exploration and validation of C-reactive protein/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma.
        J. Cancer. 2016; 7: 1406
        • Kelesoglu S.
        • Yilmaz Y.
        • Elcık D.
        Relationship between C-reactive protein to albumin ratio and coronary collateral circulation in patients with stable coronary artery disease.
        Angiology. 2021; (00033197211004392, Online ahead of print)
        • Çınar T.
        • Çağdaş M.
        • Rencüzoğulları İ.
        • et al.
        Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction.
        Scand. Cardiovasc. J. 2019; 53: 83-90
        • Guo S.
        • Wang M.
        • Yu Y.
        • et al.
        The association of erythrocyte sedimentation rate, high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes.
        BMC Endocr. Disord. 2020; 20: 1-8
        • Toto R.D.
        Microalbuminuria: definition, detection, and clinical significance.
        J. Clin. Hypertens. 2004; 6: 2-7